Boryung
Boryung is a prominent South Korean public pharmaceutical company based in Seoul. Established in 1957 and listed on KOSPI in 1988, Boryung specializes in the research, development, manufacturing, and global marketing of both specialty and generic drugs. The company focuses on treating chronic diseases, particularly hypertension and cardiovascular disorders, and has a diverse portfolio that includes products for oncology, gastrointestinal issues, diabetes, and respiratory health. With a global reach, Boryung exports to nearly 50 countries across six continents, including Japan, China, Europe,
Investing activity
Boryung is listed on AI Lounge as a venture capital investor based in Seoul, Seoul, South Korea. The deals desk records Series A and later AI rounds and seeds over $10M, so smaller checks may not show here yet.
Deals
Frequently asked questions about Boryung
Where is Boryung based?
Boryung is based in Seoul, Seoul, South Korea.
How can founders reach Boryung?
Founders on AI Lounge can see Boryung's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Boryung to their Investor Pipeline to track the conversation.